Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids

World Journal of Surgery

Volumn 25, Issue 6, 2001, Pages 700-703

  Skogseid, Britt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DOXORUBICIN; FLUOROURACIL; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; STREPTOZOCIN;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; CLINICAL FEATURE; EVIDENCE BASED MEDICINE; HUMAN; LIVER METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOID TUMOR; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; INTESTINAL NEOPLASMS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; STREPTOZOCIN;

EID: 0035014530     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0017-4     Document Type: Article

References (13)

1. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor of malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index and other clinicopathologic variables
2. Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet cell carcinoma
3. Streptozotocin-doxorubicin, streptozotocin-fluorouracil, or chlorozotocin in the treatment of advanced islet cell carcinoma
4. Update on the diagnosis and treatment of rare neuroendocrine tumors
5. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin
6. Somatostatin analogue octreotide and inhibition of tumor growth in metastatic gastroenteropancreatic turnouts
7. An update on the medical treatment of malignant endocrine pancreatic tumors
8. Long-term management of the carcinoid syndrome
9. Interferon-alpha 2b, with or without prior hepatic artery embolization: Clinical response and survival in midgut carcinoid patients: The Norwegian carcinoid study
10. Octreotide and interferon alpha: A new combination for the treatment of malignant carcinoid tumours
11. Combination therapy with octreotide and alpha-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors
12. Somatostatin receptor: Scintigraphy and radionuclide therapy
13. Yttrium-90-labelled somatostatin analogue for cancer treatment